Further evidence that the central nucleus of the amygdala is associated with the ethanol-induced locomotor response

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 7, 1998, Pages 1531-1537

  Demarest, Kristin ^a   Hitzemann, Barbara ^a   Mahjubi, Elham ^a   McCaughran Jr , James ^a   Hitzemann, Robert ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amygdala; C Fos; Central Nucleus; Ethanol; Locomotion

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; FEMALE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031725531     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03946.x     Document Type: Article

References (55)

1. Crabbe JC, Johnson NA, Gray DK, Kosobud A, Young ER: Biphasic effects of ethanol on open field activity: Sensitivity and tolerance to C57BL/6N and DBA/2N mice. J Comp Physiol Psychol 96:440-451, 1982
2. Crabbe JC: Genetic differences in locomotor activation in mice. Pharmacol Biochem Behav 25:289-292, 1986
3. Dudek BC, Phillips TJ: Distinctions among sedative, disinhibitory and ataxic properties of ethanol in inbred and selectively bred mice. Psychopharmacology 101:93-99, 1990
4. Dudek BC, Phillips TJ, Hahn ME: Genetic analyses of the biphasic nature of the alcohol-dose response curve. Alcohol Clin Exp Res 15:262-269, 1991
5. Dudek BC, Tritto T: Biometrical genetic analysis of ethanol's psychomotor stimulant effect. Alcohol Clin Exp Res 18:956-963, 1994
6. Liljequist S, Berggren U, Engel J: The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation. J Neural Transm 50:57-67, 1981
7. Risinger FO, Dickinson SD, Cunningham CL: Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology 107:453-456, 1992
8. Cunningham CL, Malott DH, Dickinson SD, Risinger FO: Haloperidol does not alter expression of ethanol-induced conditioned place preference. Behav Brain Res 50:1-5, 1992
9. Broadbent J, Grahame NJ, Cunningham CL: Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization. Psychopharmacology 120:475-482, 1995
10. Shen EH, Crabbe JC, Phillips TJ: Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice. Psychopharmacology 118:28-36, 1995
11. Blomqvist O, Engel JA, Nissbrandt H, Soderpalm B: The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol 249:207-213, 1993
12. Trifunovic RD, Brodie MS: The effects of clomipramine in the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro. J Pharmacol Exp Ther 276:34-40, 1996
13. Erwin VG, Su NC: Neurotensin and ethanol interactions on hypothermia and locomotor activity in LS and SS mice. Alcohol Clin Exp Res 13:91-94, 1989
14. Erwin VG, Jones BC: Genetic correlations among ethanol-related behaviors and neurotensin receptors in long sleep (LS) × short sleep (SS) recombinant inbred strains of mice. Behav Genet 23:191-196, 1993
15. Erwin VG, Jones BC, Myer SR: Effects of acute and chronic ethanol administration on neurotensinergic systems. Ann NY Acad Sci 739:185-196, 1994
16. Hitzemann R, Hitzemann B, Kanes S, Dains K: Genetics and organization of the basal ganglia, in Bradley RJ and Harris RA (eds): The International Review of Neurobiology, vol 38. San Diego, Academic Press, 1995, pp 43-94
17. Dains K, Hitzemann B, Hitzemann R: Genetics, neuroleptic response and the organization of the cholinergic neurons in the mouse striatum. J Pharmacol Exp Ther 279:1430-1438, 1996
18. Hitzemann B, Hitzemann R: Genetics, ethanol, and the Fos response: A comparison of the C57BL/6J and DBA/2J inbred mouse strains. Alcohol Clin Exp Res 21:1497-1507, 1997
19. Morgan JI, Cohen DR, Hempstead JL, Curran T: Mapping patterns of c-Fos expression in the central nervous system after seizure. Science 237:192-197, 1987
20. Morgan JI, Curran T: Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Ann Rev Neurosci 14:421-451, 1991
21. Chang SL, Patel NA, Romero AA: Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res 679:89-98, 1995
22. Ryabinin AE, Criado JR, Henrikson SJ, Bloom FE, Wilson MC: Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of ethanol. Mol Psychol 2:32-43, 1996
23. Alheid GF, de Olmos JS, Beltramino CA: Amygdala and extended amygdala, in Paxinos G (ed): The Rat Nervous System, ed 2. San Diego, Academic Press, 1995, pp 495-578
24. Phillips TJ, Beadles-Bohling A, Burkhart-Kasch S, Lessov CN: Absent ethanol stimulant response in 5HT1B knockout mice. Alcohol Clin Exp Res 21:7A, 1997
25. Davis M, Rainnie D, Cassell M: Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17:208-214, 1994
26. Lander ES, Botstein E: Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121:185-199, 1989
27. McCaughran JA Jr, Cipp L, Ramphir N, Mahjubi E, Hitzemann R: QTL analysis of ethanol-induced activation: A preliminary report. Alcohol Clin Exp Res 21:15A, 1997
28. Chan RK, Sawchenko PE: Hemodynamic regulation of tyrosine hydroxylase messenger RNA in medullary catecholaminergic neurons: A c-Fos-guided hybridization histochemical study. Neuroscience 66:377-390, 1995
29. Franklin KBJ, Paxinos G: The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1997
30. Franza BR Jr, Sambucetti LC, Cohen DR, Cunnan T: Analysis of Fos protein complexes and Fos-related antigens by high-resolution two-dimensional gel electrophoresis. Oncogene 1:213-221, 1987
31. Franza BR Jr, Rauscher FJ III, Josephs SF, Curran T: The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239:1150-1153, 1988
32. Sonnenberg JL, Mitchelmore C, MacGregor-Leon PF, Hempstead J, Morgan JI, Curran T: Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in mammalian brain. J Neurosci Res 24:72-80, 1989
33. Dragunow M, Robertson GS, Faull LM, Robertson HA, Jansen K: D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37:287-294, 1990
34. Dilts RP, Helton TE, McGinty JE: Selective induction of Fos and Fra immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse 13:251-263, 1993
35. Davis M: The role of the amygdala in fear and anxiety. Ann Rev Neurosci 15:353-376, 1992
36. Sun N, Cassell MD: Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol 330:381-404, 1993
37. McDonald AJ: Cytoarchitecture of the central amygdaloid nucleus in the rat. J Comp Neurol 208:401-408, 1982
38. McDonald AJ: Neurons of the bed nucleus of the stria terminalis: A Golgi study in the rat brain. Brain Res Bull 10:111-120, 1983
39. Arluison MF, Javoy-Agid C, Feuerstein M, Taue M, Conrath-Verrier M, Mailly P: Histofluorescence analysis of several systems of catecholaminergic nerve fibers within the rat neostriatum revealed by either restricted lesions of the substantia nigra or gamma-hydroxybutyrate. Brain Res Bull 9:355-365, 1982
40. Hopkins DA, Holstege G: Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Exp Brain Res 32:529-547, 1978
41. Gonzales C, Chesselet M-F: Amygdalonigral pathway: An antero-grade study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L). J Comp Neurol 297:182-200, 1991
42. Rassnick S, Heinrichs SC, Britton KT, Koob GF: Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32, 1993
43. Roberts AJ, Cole M, Koob GF: Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res 20:1289-1298, 1996
44. Salminen O, Lahtinen S, Ahtee L: Expression of Fos protein in various rat brain areas following acute nicotine and diazepam. Pharmacol Biochem Behav 54:241-248, 1996
45. Beck CH, Fibiger HC: Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-Fos: With and without diazepam pretreatment. J Neurosci 15(1 Pt. 2):709-720, 1995
46. Hitzemann B, Hitzemann R: Differential Fos response in the central nucleus the amygdala of C57BL/6J and DBA/2J inbred mouse strains to chlordiazepoxide. Res Soc Alcohol June 22:53A, 1998 (abstr)
47. Green S, Vale AL: Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav Pharmacol 3:35-41, 1992
48. Pesold C, Treit D: The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671: 213-221, 1995
49. Curran T, Morgan JI: Fos: An immediate early transcription factor in neurons. J Neurobiol 26:403-412, 1995
50. Patel N, Hitzemann B, Hitzemann R: Genetics, haloperidol and the Fos response in the basal ganglia: A comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology 18:480-491, 1998
51. Soller M, Brody T, Genizi A: On the power of experimental designs for the detection of linkage between marker loci and quantitative loci in crosses between inbred lines. Theor Appl Genet 47:35-39, 1976
52. Darvasi A: Interval-specific congenic strains (ISCS): An experimental design for mapping a QTL into a 1-centimorgan interval. Mam Genome 8:163-167, 1997
53. Hitzemann B, Dains K, Kanes S, Hitzemann R: Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. J Pharmacol Exp Ther 271:969-976, 1994
54. Kanes S, Hitzemann B, Hitzemann R: Mapping the genes for haloperidol-induced catalepsy. J Pharmacol Exp Ther 277:1016-1025, 1996
55. Belknap JK, Richards SP, O'Toole LA, Helms ML, Phillips TJ: Short-term selective breeding as a tool for QTL mapping: Ethanol preference drinking in mice. Behav Genet 27:55-66, 1997